中国西北地区汉,回,维,藏民族HLA—DRB基因多态性的研究

按照第１１届国际相容性抗原研讨会工作会议ＨＬＡⅡ类ＰＣＲ－ＳＳＯ分型标准和美国国立骨髓供者计划组织对ＨＬＡ ＤＲＢ位点等位基因分型要求,设计合成１对引物,扩增ＨＬＡ ＤＲＢ ＤＮＡ片段,长度为２５６ｂｐ,设计合成不同片段大小探针２７种,可检出ＤＲＢ座位上ＤＲＢ１的３９种等位基因,ＤＲＢ３的３种等位基因,ＤＲＢ４的１种等位基因和ＤＲＢ５的３４种等位基因。     

HLA—DRB1基因位点多态性的PCR—RFLP分析

设计并建立了一套适合国内应用的改良ＰＣＲ－ＲＦＬＲ方法,分５组特异性扩增ＤＮＡ样品,随后进行酶切定型分析,准确检测了编码ＤＲ抗原特异性ＨＬＡ－ＤＲＢ１基因位点的多态性,该法采用分组扩增,不发生与其它ＤＲＢ位点等位基因的交叉扩增,不仅适合纯合子的区分而且可以清楚准确地检测杂合子样品。     

HLA-DRB1 等位基因的多态性及其应用

HLA系统参与和调节机体免疫功能,是人类重要的遗传标志,具有种族、地域差异.HLA-Ⅱ类系统中DRB1等位基因的多态性最丰富,它的准确分型直接影响器官移植的供体选择、法医学个体认定、HLA与疾病相关性及人类学等研究.本文综述了HLA-DRB1分型检测方法,不同种族人群HLA-DRB1等位基因的多态性,HLA-DRB1多态性研究在探讨人类起源、民族融合方面的价值,HLA-DRB1与肝炎、系统性红斑狼疮等疾病的相关性等.     

HLA－DRB1基因位点多态性的PCR－RFLP分析

设计并建立一套适合国内应用的改良ＰＣＲ－ＲＦＬＲ方法,分５组特异性扩增ＤＮＡ样品,随后进行酶切定型分析,准确检测了编码ＤＲ抗原特异性的ＨＬＡ－ＤＲＢ１基因位点的多态性,该法采用分组扩增,不发生与其它ＤＲＢ位点等位基因的交叉扩增,不仅适合纯合子的区分而且可以清楚准确地检测杂合子样品,已报道过的ＤＲＢ１位点编码的特异性组合都可以通过这个方法得到准确分析。所使用的Ⅱ类限制性内切酶均价格便宜、易购。     

云南纳西族HLA—DRB1基因多态性研究及其族源分析

首次在国内采用本室改进的高分辨率的基于内含子的PCR－SBT分型方法,检测云南纳西族HLA－DRB1基因多态性。在60例纳西族个体中共检出37种HLA－DRB1等位基因,其显著特点是等位基因的类型检出较多,频率分布比较平均,除12021（17.50%）外其他的等位基因频率均低于8％,其他较常见的等位基因（＞5％）还有1404（7.50%）,1504（5.83%0,04051（5.83%0,08032（5.83%）,09012（5％）,03011（5％）。这几种中频等位基因共占可检出等位基因的35％,与12021一起共占52.49%,其中DRB1＊0305、0438、1123、1132、1310、0812为首次在我国人群中检出,并且在世界各地人群中也比较罕见。以纳西族和世界各地人群的HLA－DRB1频率进行了聚类分析。比较分析的结果显示纳西族明显属于中国南方族群,未显示出其族源来自北方的痕迹。根据遗传数据,并参照民族学、历史学研究,对其民族起源做了初步的分析。     

甘肃裕固族HLA—DRB1基因多态性及其族源分析

目的：研究甘肃裕固族HLA—DRB1基因的多态性,探讨裕固族的起源、迁徙及其与其他民族的关系。方法：应用PCR-SSP基因分型技术,对54例裕固族个体进行了HLA-DRB1位点的基因分型并进行相应等位基因频率的比较。结果：甘肃裕固族HLA-DRB1位点共检出了14种等位基因,其中高频基因为DR5（0、2115）,DR4（0、1346）和DR7（0．1250）,低频的等住基因为DR14（0．0096）和DR13（0．0192）;裕固族人HLA-DRB1座位等位基因总的分布格局与蒙古族最接近,与云南黎族则相差较远。结论：对裕固族和我国各地人群的HLA-DRB1频率进行了聚类分析,极为相似的HLA-DRB1背景提示裕固族和蒙古族之间密切的遗传关系。     

用PCR—RFLP方法研究藏族HLA0—DQA1和—DQB1基因多态性

应用目前ＨＬＡ研究领域中成熟的、有效的ＰＣＲ－ＲＦＬＰ基因分型技术,从ＤＮＡ水平对藏族健康群体进行了ＨＬＡ－ＤＱＡ１（４９人）和－ＤＱＢ１（４９人）基因分型,这在国内外属首次。所采用的ＰＣＲ－ＲＦＬＰ基因分型技术是在ＨＬＡ－ＤＱＡ１和－ＤＱＢ１各等位基因全部序列已知的情况下,对其第２个外显子碱基序列扩增进而进行ＲＦＬＰ分析的方法。这种方法得到的ＲＦＬＰ的所有片段都是已知序列,因而精确度很高,同时为     

新疆吐鲁番地区维吾尔族HLA-DQA1等位基因多态性研究

目的：探讨新疆吐鲁番地区维吾尔族HLA—DQA1等位基因多态性。方法：采用聚合酶链反应一序列特异性引物技术,检测107例新疆吐鲁番地区维吾尔族健康个体的HLA—DQA1等位基因频率,分析HLA—DQA1基因多态性,并将所得结果与国内其他民族的同类资料进行比较。结果：新疆吐鲁番地区维吾尔族健康个体中共检出10个等位基因,以DQA1＊0104（O．3727）、DQA1＊0501（0．2636）、DQA1＊0103（0．1318）的频率较高,DQA1＊0401（0．0045）、DQA1＊0601（0．0091）的频率较低。结果与国内其他民族的同类资料进行比较,等位基因分布频率上有共同点,也有一定的独特性。结论：新疆吐鲁番地区维吾尔族HLA—DQA1基因,与国内其他民族群体的资料比较,总体检验有显著差异（p〈0．01）,显示人类的遗传系统既有共性亦有各自的特点,显示华人群体遗传背景的复杂性,结果为人类学研究和HLA—DQA1基因相关的疾病提供了较为重要的信息.     

新疆维吾尔族,哈萨克族人群HLA—DQA1,—DQB1两基因座多态性的研究？…

应用ＰＣＲ－ＲＦＬＰ基因分型技术,首次对我国新疆地区维吾尔族和哈萨克族２个少数民族群体的ＨＬＡ－ＤＱＡ１,－ＤＱＢ１两个基因座的多态性进行了研究,结果显示,在ＤＱＡ１８个等位基因中,维族和哈族表现为ＤＱＡ１＊０３０１最常见,最少见的ＤＱＡ１等位基因,在维族中的ＤＱＡ１＊０４０１和０６０１,而在哈族中ＤＱＡ１＊０６０１;在ＤＱＢ１１６个等位基因中,ＤＱＢ１＊０２０１和＊０３０１在维族和哈族中均表现为     

HLA—DRB1基因多态性与溃疡性结肠炎的相关性研究进展

溃疡性结肠炎（Ulcerativecolitis,uc）是一种直肠和结肠的慢性非特异性炎症性疾病,其病因至今仍未完全阐明,普遍认为与遗传因素和自身免疫异常有关。人类白细胞抗原（Humanleukocyteantigen,HLA）是人类主要组织相容性复合体（MHC）基因的编码产物,是调控人类免疫应答的关键因素之一,其中HLAII类基因参与外源性抗原的递呈,是目前研究的最为广泛的与炎症性肠病相关的区域。HLAII类基因中以HLA—DRB1等位基因的多态性最丰富,国内外大量研究均显示HLA—DRB1基因不仅与uc的发病密切相关,而且与UC的临床特点有关联,但研究的结果并不完全一致,而且其导致特定人群UC易感的分子生物学机制也不十分清楚。本文主要综述HLA．DRB1基因多态性与uc相关性的研究进展。     

A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions

Human leukocyte antigens (HLA) or histocompatibility molecules are glycoproteins that play a pivotal role in the development of an effective immune response. An important function of the HLA molecules is the ability to bind and present antigen peptides to T lymphocytes. Presently there is no comprehensive way of predicting and energetically evaluating peptide binding on HLA molecules. To quantitatively determine the binding specificity of a class II HLA molecule interacting with peptides, a novel decomposition approach based on deterministic global optimization is proposed that takes advantage of the topography of HLA binding grove, and examined the interactions of the bound peptide with the five different pockets. In particular, the main focus of this paper is the study of pocket 1 of HLA DR1 (DRB1*0101 allele). The determination of the minimum energy conformation is based on the ECEPP/3 potential energy model that describes the energetics of the atomic interactions. The minimization of the total potential energy is formulated on the set of peptide dihedral angles, Euler angles, and translation variables to describe the relative position. The deterministic global optimization algorithm, αBB, which has been shown to be ϵ-convergent to the global minimum potential energy through the solution of a series of nonlinear convex optimization problems, is utilized. The PACK conformational energy model that utilizes the ECEPP/3 model but also allows the consideration of protein chain interactions is interfaced with αBB. MSEED, a program used to calculate the solvation contribution via the area accessible to the solvent, is also interfaced with αBB. Results are presented for the entire array of naturally occurring amino acids binding to pocket 1 of the HLA DR1 molecule and very good agreement with experimental binding assays is obtained. Proteins 29:87–102, 1997. © 1997 Wiley-Liss, Inc.     

A Single Nucleotide Polymorphism and Sequence Analysis of CSN1S1 Gene Promoter Region in Chinese BOS Grunniens (YAK)

The aim of this study was to investigate the polymorphism of the CSN1S1 gene promoter region in 4 Chinese yak breeds, and compare the yak CSN1S1 gene promoter region sequences with other ruminants. A Polymerase Chain Reaction-Single Strand Conformation Polymorphism protocol was developed for rapid genotyping of the yak CSN1S1 gene. One hundred fifty-eight animals from 4 Chinese yak breeds were genotyped at the CSN1S1 locus using the protocol developed. A single nucleotide polymorphism of the CSN1S1 gene promoter region has been identified in all yak breeds investigated. The polymorphism consists of a single nucleotide substitution G→A at position 386 of the CSN1S1 gene promoter region, resulting in two alleles named, respectively, G₃₈₆ and A₃₈₆, based on the nucleotide at position 386. The allele G₃₈₆ was found to be more common in the animals investigated. The corresponding nucleotide sequences in GenBank of yak (having the same nucleotides as allele G₃₈₆ in this study), bovine, water buffalo, sheep, and goat had similarity of 99.68%, 99.35%, 97.42%, 95.14%, and 94.19%, respectively, with the yak allele A_386.     

In silico prediction and immunological validation of common HLA-DRB1-restricted T cell epitopes of Candida albicans secretory aspartyl proteinase 2

ABSTRACT Sap2 is the most abundant virulence factor expressed during Candida infection, and the principal protein known to induce antibody response during Candida infection in humans. Its role in T-cell activation however, has not yet been determined. Sequence analysis revealed that Sap2 contains two variable regions: Var1 and Var2. Computational predictions by the Hotspot Hunter program identified that Var1 contains three candidate T-cell epitopes, whereas Var2 contains four. Thirty-nine overlapping peptides of Sap2 were then synthesized, and tested for their ability to induce proliferation of PBMC from 12 donors. Peptides P11, P17 and P31 exhibited significantly higher proliferative indices when compared with those of other peptides or controls. P17 and P31 are located in the areas of prediction, while P11 is not. There were other peptides outside the prediction areas that could stimulate PBMC proliferation at low levels. Nevertheless, the proliferative noise caused by such peptides was ruled out by IL-2 ELISpot analysis. Only P17 and P31 were shown to induce clonal proliferation of IFN-gamma producing lymphocytes, suggesting that these two peptides contain T cell epitopes. P11, which stimulated IL-2 producing clones, contains a known B-cell epitope. Interestingly, P17 and P31 elicited both Th1 and Th2 cell responses with significant numbers of IL-13 secreting clones in response to stimulation. Taken together, the computer-based T cell epitope prediction method could identify the immunogenic T cell epitopes of C. albicans Sap2 that promiscuously bind to the HLA-DRB1 supertype.     

中国广东人红细胞PGM_1亚型遗传性多态现象

采用薄层聚丙烯酰胺凝胶等电聚焦技术,调查了中国(广东)406名无亲缘关系的正常人红细胞磷酸葡萄糖变位酶-1(PGM_1)亚型的遗传多态性。除了常见的10种亚型外,还发现了由一个新的变异型等位基因和常见的4个等位基因杂合产生的9例变异型。PGM_1位点的等位基因频率PGM_1~(1+)、PGM_1~(1-)、PGM_1~(2+)、PGM-1~(2-)和PGM_1~(V丰)(变异型等位基因)分别为0.5973、0.1256、0.1724、0.0936和0.0111;群体处于Hardy-Weinberg式平衡状态。变异型等位基因以多态频率出现,可能成为该群体的一个重要的遗传性特征。     

新疆哈萨克族脑梗塞与ICAM-1基因G241R多态性的关系

目的：探讨新疆哈萨克族脑梗死与细胞黏附分子1（ICAM-1）G241R基因多态性的关系。方法：采用多聚酶链式反应法及限制性内切酶片段长度多态性技术,对新疆哈萨克族100例脑梗死患者及110例健康者（对照组）进行ICAM-1基因G241R多态性检测,比较不同基因型与哈萨克族脑梗塞发病风险的关系。结果：脑梗塞患者ICAM-1基因G41R多态性的基因型频率和等位基因频率与健康对照组相比无明显差异。结论：ICAM-1基因G214R多态性可能不是新疆哈萨克族脑梗塞发病的遗传学危险因素。     

Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population

Immunogenetic host factors are associated with susceptibility or protection to tuberculosis (TB). Strong associations of HLA class II genes with TB are reported. We analyzed the HLA-DRB1*04 alleles to identify subtypes associated with pulmonary TB and their interaction with risk factors such as alcohol, smoking, and gender in 316 pulmonary TB patients and 306 healthy individuals from the Brazilian Amazon. The HLA-DRB1*04 was prevalent in patients with pulmonary TB (p<0.0001; OR = 2.94; 95% CI = 2.12 to 4.08). Direct nucleotide sequencing of DRB1 exon 2 identified nine subtypes of HLA-DRB1*04. The subtype HLA-DRB1*04:11:01 (p = 0.0019; OR = 2.23; 95% CI = 1.34 to 3.70) was associated with susceptibility to pulmonary TB while DRB1*04:07:01 (p<0.0001; OR = 0.02; 95% CI = 0.001 to 0.33) to protection. Notably, the interaction between alcohol and HLA-DRB1*04:11:01 increased the risk for developing pulmonary TB (p = 0.0001; OR = 51.3; 95% CI = 6.81 to 386). Multibacillary pulmonary TB, the clinical presentation of disease transmission, was strongly associated with interaction to alcohol (p = 0.0026; OR = 11.1; 95% CI = 3.99 to 30.9), HLA-DRB1*04:11:01 (p = 0.0442; OR = 2.01; 95% CI = 1.03 to 3.93) and DRB1*04:92 (p = 0.0112; OR = 8.62; 95% CI = 1.63 to 45.5). These results show that HLA-DRB1*04 are associated with pulmonary TB. Interestingly, three subtypes, DRB1*04:07:01, DRB1*04:11:01 and DRB1*04:92 of the HLA-DRB1*04 could be potential immunogenetic markers that may help to explain mechanisms involved in disease development.